List of Tables
Table 1. Kinase Inhibitors Market Trends
Table 2. Kinase Inhibitors Market Drivers & Opportunity
Table 3. Kinase Inhibitors Market Challenges
Table 4. Kinase Inhibitors Market Restraints
Table 5. Global Kinase Inhibitors Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Kinase Inhibitors Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Kinase Inhibitors Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Kinase Inhibitors Product Type
Table 9. Key Companies Time to Begin Mass Production of Kinase Inhibitors
Table 10. Global Kinase Inhibitors Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinase Inhibitors as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Kinase Inhibitors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Kinase Inhibitors Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Kinase Inhibitors Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Kinase Inhibitors Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Kinase Inhibitors Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Kinase Inhibitors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Kinase Inhibitors Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Kinase Inhibitors Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Kinase Inhibitors Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Kinase Inhibitors Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Kinase Inhibitors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Kinase Inhibitors Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Kinase Inhibitors Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Kinase Inhibitors Sales Value by Region (2019-2024) & (%)
Table 27. Global Kinase Inhibitors Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Kinase Inhibitors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Kinase Inhibitors Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Kinase Inhibitors Sales Value, (2025-2030) & (US$ Million)
Table 31. Merck Basic Information List
Table 32. Merck Description and Business Overview
Table 33. Merck Kinase Inhibitors Products, Services and Solutions
Table 34. Revenue (US$ Million) in Kinase Inhibitors Business of Merck (2019-2024)
Table 35. Merck Recent Developments
Table 36. Novartis Basic Information List
Table 37. Novartis Description and Business Overview
Table 38. Novartis Kinase Inhibitors Products, Services and Solutions
Table 39. Revenue (US$ Million) in Kinase Inhibitors Business of Novartis (2019-2024)
Table 40. Novartis Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Kinase Inhibitors Products, Services and Solutions
Table 44. Revenue (US$ Million) in Kinase Inhibitors Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Sanofi Basic Information List
Table 47. Sanofi Description and Business Overview
Table 48. Sanofi Kinase Inhibitors Products, Services and Solutions
Table 49. Revenue (US$ Million) in Kinase Inhibitors Business of Sanofi (2019-2024)
Table 50. Sanofi Recent Developments
Table 51. GlaxoSmithKline Basic Information List
Table 52. GlaxoSmithKline Description and Business Overview
Table 53. GlaxoSmithKline Kinase Inhibitors Products, Services and Solutions
Table 54. Revenue (US$ Million) in Kinase Inhibitors Business of GlaxoSmithKline (2019-2024)
Table 55. GlaxoSmithKline Recent Developments
Table 56. Biogen Idec Basic Information List
Table 57. Biogen Idec Description and Business Overview
Table 58. Biogen Idec Kinase Inhibitors Products, Services and Solutions
Table 59. Revenue (US$ Million) in Kinase Inhibitors Business of Biogen Idec (2019-2024)
Table 60. Biogen Idec Recent Developments
Table 61. Bayer Healthcare Pharmaceuticals Basic Information List
Table 62. Bayer Healthcare Pharmaceuticals Description and Business Overview
Table 63. Bayer Healthcare Pharmaceuticals Kinase Inhibitors Products, Services and Solutions
Table 64. Revenue (US$ Million) in Kinase Inhibitors Business of Bayer Healthcare Pharmaceuticals (2019-2024)
Table 65. Bayer Healthcare Pharmaceuticals Recent Developments
Table 66. Johnson Basic Information List
Table 67. Johnson Description and Business Overview
Table 68. Johnson Kinase Inhibitors Products, Services and Solutions
Table 69. Revenue (US$ Million) in Kinase Inhibitors Business of Johnson (2019-2024)
Table 70. Johnson Recent Developments
Table 71. Tolero Pharmaceutical Basic Information List
Table 72. Tolero Pharmaceutical Description and Business Overview
Table 73. Tolero Pharmaceutical Kinase Inhibitors Products, Services and Solutions
Table 74. Revenue (US$ Million) in Kinase Inhibitors Business of Tolero Pharmaceutical (2019-2024)
Table 75. Tolero Pharmaceutical Recent Developments
Table 76. Astellas Pharma Inc Basic Information List
Table 77. Astellas Pharma Inc Description and Business Overview
Table 78. Astellas Pharma Inc Kinase Inhibitors Products, Services and Solutions
Table 79. Revenue (US$ Million) in Kinase Inhibitors Business of Astellas Pharma Inc (2019-2024)
Table 80. Astellas Pharma Inc Recent Developments
Table 81. Eli Lilly and Co Basic Information List
Table 82. Eli Lilly and Co Description and Business Overview
Table 83. Eli Lilly and Co Kinase Inhibitors Products, Services and Solutions
Table 84. Revenue (US$ Million) in Kinase Inhibitors Business of Eli Lilly and Co (2019-2024)
Table 85. Eli Lilly and Co Recent Developments
Table 86. Incyte Corp Basic Information List
Table 87. Incyte Corp Description and Business Overview
Table 88. Incyte Corp Kinase Inhibitors Products, Services and Solutions
Table 89. Revenue (US$ Million) in Kinase Inhibitors Business of Incyte Corp (2019-2024)
Table 90. Incyte Corp Recent Developments
Table 91. AstraZeneca Basic Information List
Table 92. AstraZeneca Description and Business Overview
Table 93. AstraZeneca Kinase Inhibitors Products, Services and Solutions
Table 94. Revenue (US$ Million) in Kinase Inhibitors Business of AstraZeneca (2019-2024)
Table 95. AstraZeneca Recent Developments
Table 96. Bristol-Myers Squibb Basic Information List
Table 97. Bristol-Myers Squibb Description and Business Overview
Table 98. Bristol-Myers Squibb Kinase Inhibitors Products, Services and Solutions
Table 99. Revenue (US$ Million) in Kinase Inhibitors Business of Bristol-Myers Squibb (2019-2024)
Table 100. Bristol-Myers Squibb Recent Developments
Table 101. Boehringer Ingelheim International GmbH Basic Information List
Table 102. Boehringer Ingelheim International GmbH Description and Business Overview
Table 103. Boehringer Ingelheim International GmbH Kinase Inhibitors Products, Services and Solutions
Table 104. Revenue (US$ Million) in Kinase Inhibitors Business of Boehringer Ingelheim International GmbH (2019-2024)
Table 105. Boehringer Ingelheim International GmbH Recent Developments
Table 106. F. Hoffmann-La Roche Ltd Basic Information List
Table 107. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 108. F. Hoffmann-La Roche Ltd Kinase Inhibitors Products, Services and Solutions
Table 109. Revenue (US$ Million) in Kinase Inhibitors Business of F. Hoffmann-La Roche Ltd (2019-2024)
Table 110. F. Hoffmann-La Roche Ltd Recent Developments
Table 111. Eisai Co., Ltd. Basic Information List
Table 112. Eisai Co., Ltd. Description and Business Overview
Table 113. Eisai Co., Ltd. Kinase Inhibitors Products, Services and Solutions
Table 114. Revenue (US$ Million) in Kinase Inhibitors Business of Eisai Co., Ltd. (2019-2024)
Table 115. Eisai Co., Ltd. Recent Developments
Table 116. BerGenBio Basic Information List
Table 117. BerGenBio Description and Business Overview
Table 118. BerGenBio Kinase Inhibitors Products, Services and Solutions
Table 119. Revenue (US$ Million) in Kinase Inhibitors Business of BerGenBio (2019-2024)
Table 120. BerGenBio Recent Developments
Table 121. Rigel Pharmaceuticals Basic Information List
Table 122. Rigel Pharmaceuticals Description and Business Overview
Table 123. Rigel Pharmaceuticals Kinase Inhibitors Products, Services and Solutions
Table 124. Revenue (US$ Million) in Kinase Inhibitors Business of Rigel Pharmaceuticals (2019-2024)
Table 125. Rigel Pharmaceuticals Recent Developments
Table 126. Mirati Therapeutics Basic Information List
Table 127. Mirati Therapeutics Description and Business Overview
Table 128. Mirati Therapeutics Kinase Inhibitors Products, Services and Solutions
Table 129. Revenue (US$ Million) in Kinase Inhibitors Business of Mirati Therapeutics (2019-2024)
Table 130. Mirati Therapeutics Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Kinase Inhibitors Downstream Customers
Table 134. Kinase Inhibitors Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Kinase Inhibitors Product Picture
Figure 2. Global Kinase Inhibitors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Kinase Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 4. Kinase Inhibitors Report Years Considered
Figure 5. Global Kinase Inhibitors Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Kinase Inhibitors Revenue in 2023
Figure 7. Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Non-receptor Tyrosine Kinase Inhibitors Picture
Figure 9. Receptor Tyrosine Kinase Inhibitors Picture
Figure 10. Multikinase Inhibitors Picture
Figure 11. Serine/Threonine Kinase Inhibitors Picture
Figure 12. Protein Kinase C Inhibitors Picture
Figure 13. RHO Kinase Inhibitors Picture
Figure 14. Others Picture
Figure 15. Global Kinase Inhibitors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Kinase Inhibitors Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Oncology
Figure 18. Product Picture of Inflammatory Diseases
Figure 19. Product Picture of Others
Figure 20. Global Kinase Inhibitors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Kinase Inhibitors Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Kinase Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Kinase Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Kinase Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Kinase Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Kinase Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Kinase Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Kinase Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Kinase Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Kinase Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Kinase Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Kinase Inhibitors Sales Value (%), (2019-2030)
Figure 33. United States Kinase Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Kinase Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Kinase Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Kinase Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Kinase Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Kinase Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 39. China Kinase Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Kinase Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 41. China Kinase Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Kinase Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Kinase Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Kinase Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Kinase Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Kinase Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Kinase Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Kinase Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Kinase Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Kinase Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 51. India Kinase Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Kinase Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 53. India Kinase Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 54. Kinase Inhibitors Industrial Chain
Figure 55. Kinase Inhibitors Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
